in this third cooperative chemotherapy trial of the national prostatic cancer project 165 patients with histologically confirmed , relapsing clinical stage d prostatic cancer were randomized to receive either imidazole-carboxamide , procarbazine or cyclophosphamide .
C0033572
prostatic
C3146265
stage d